The Global Europe IV Hydration Therapy Market Growth Accelerated By Growing Awareness Of Benefits Of IV Hydration Therapy
IV hydration therapy provides intravenous fluid administration directly into the bloodstream to treat dehydration and electrolyte imbalances. It is useful for patients suffering from diarrhea, vomiting, kidney disease, ulcers, or hangovers. The therapy allows delivery of precise amounts of fluids and nutrients required by the body in a convenient manner. The Europe IV hydration therapy market is gaining traction owing to increasing awareness about its benefits over oral hydration.
The global Europe IV hydration therapy Market is estimated to be valued at US$ 261.68 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
People are increasingly opting for IV hydration therapy to treat dehydration caused by hangovers, traveler’s sickness, work or activity-related exhaustion and jet lag. Various clinics offering quick access to IV therapy are cropping up in urban areas to cater to busy lifestyles. For instance, companies like Infusion By Clinigen offer IV rehydration services via their centers located across the UK. Convenience and immediate relief offered by IV treatment compared to oral hydration is boosting the demand. Increased adoption of preventive healthcare approach is also contributing to market expansion. People are using IV therapy to stay hydrated and energetic before or after intensive workouts or social events involving alcohol consumption.
Segment Analysis
The Europe IV hydration therapy market is segmented into type and end users. Based on type, the market is bifurcated into clinical use and non-clinical use. The clinical use segment currently dominates the market due to rising cases of chronic illnesses like cancer where IV therapy provides quick hydration. Moreover, several ambulatory clinics are also offering IV therapy for hangovers which has further increased the demand for clinical use segment.
Key Takeaways
The Europe IV Hydration Therapy Market Size is estimated to be valued at US$ 261.68 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.
Regional analysis: Western Europe is currently the largest market for IV hydration therapy in the region. The growth can be attributed to high incidences of chronic diseases such as cancer coupled with rising healthcare expenditure in countries like Germany, UK, France and Italy. However, Eastern Europe is expected to witness the fastest CAGR during the forecast period driven by increasing public awareness about health and wellness.
Key players: Key players operating in the Europe IV hydration therapy market are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Baxter, ICU Medical Inc, B. Braun Melsungen AG. Thermal Fisher Scientific dominates the market share due to its diversified product portfolio for clinical nutrition across the region. Bio-rad Laboratories has a strong foothold in the non-clinical use segment with its innovative offerings for sports and wellness industry.
Get more insights on this topic:
Comments
0 comment